Wetvax testing services
Ended Purchase Order Awarded Last action
- Contract number
- HHSD2002017M94002P
- Awardee
-
Sanofi Pasteur Biologics, LLC UEI C2ELHL5EFZD3
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $121,618
Award facts
- Opportunity
-
- 2017Q66784 Solicitation number
- Contract value 100% obligated
- $121,618.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $121,618.00 firm fixed price purchase order to Sanofi Pasteur Biologics, LLC, a for-profit foreign-owned organization, for WETVAX testing services. The contract was awarded on May 11, 2017 with a completion date of September 30, 2017. The place of performance is Cambridge, MA 02139, USA. This contract was not set aside for any specific socioeconomic program.
Quick answers
Who was awarded contract HHSD2002017M94002P?
HHSD2002017M94002P was awarded to Sanofi Pasteur Biologics, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on May 11, 2017.
How much is contract HHSD2002017M94002P worth?
The government has obligated $121,618 on HHSD2002017M94002P.
Was contract HHSD2002017M94002P competed?
The extent of competition for HHSD2002017M94002P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award